4
Changes in Ownership
Rani Therapeutics Holdings, Inc. Filed Acc 0001179110-22-002127
Director acquired 2,309,490 shares (conversion)
- Director acquired 2,309,490 shares (conversion)
- Director disposed of 2,229,238 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Farquharson Andrew · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-07 | Conversion : show line 1 in the form | −2,309,490 | 256,623 | I |
| 2022-03-07 | Conversion : show line 2 in the form | +2,309,490 | 2,375,617 | I |
| 2022-03-07 | Other disposition : show line 3 in the form | −2,229,238 | 146,379 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-07 | Conversion : show line 4 in the form Class A Common LLC Units | −2,309,490 | 256,623 | I |
Loading xslF345X03/edgar.xml…